BioSpace News Archive

Peroxfarma, which is introducing the Epaplus Arthicare supplement product line to the U.S. market this year, urges everyone to take stock of their aches and pains during National Arthritis Awareness Month.

Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced the appointment of Allan L. Shaw, CPA, as the company’s Chief Financial Officer (CFO)

ColoradoCBDSeed.com, an HM Health LLC company, announced that it has partnered and signed a multi-year contract to supply high-quality organic hemp seed to AZ Hemp, whose partners include Melissa Winnaman and Alan Bornt, one of the largest USDA organic spinach and spring mix farmers in the country.

VALBIOTIS (FR0013254851 – ALVAL / PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the successful industrial production of VALEDIA® (active substance TOTUM-63), the most advanced product in the VALBIOTIS portfolio

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa®1 (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.

Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) approved REVLIMID® (lenalidomide) in combination with a rituximab product (R²) for the treatment of adult patients with previously treated follicular lymphoma (FL) or marginal zone lymphoma (MZL) following Priority Review designation.

Sensible Medical Innovations and Bayer successfully signed an agreement making Bayer, Sensible’s largest customer in Europe.

The International Nut and Dried Fruit Council celebrated the 38th World Nut and Dried Fruit Congress from May 23 to 25, 2019, in Boca Raton Resort & Club, Florida.

Koskie Minsky LLP has commenced a class action on behalf of residents of the Restigouche Hospital Centre, also known as the Provincial Hospital, against the Province of New Brunswick and the Vitalité Health Network.

Ra Pharmaceuticals, Inc. announced that senior management will present at the following upcoming investor conferences